drugset / Trial / NCT00174720

Efficacy of Ciclesonide vs Placebo Administered as Once Daily or Twice Daily in Patients Not Treated With Inhaled Corticosteroid.

NCT00174720

Phase 3 Completed 708 enrolled Sanofi
RandomizedParallel-groupDouble-blindTreatment

Summary

To investigate the efficacy of ciclesonide MDI either as once daily or twice daily in patients with mild to moderate asthma, who have not previously been treated with an inhaled corticosteroid.

Timeline

Start
2005-09
Primary completion
2007-02
Completion
2007-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Ciclesonide Other / unclassified 80 ug Inhaled
Subject Ciclesonide Other / unclassified 160 ug Inhaled

Indications